The popular prescription weight loss drug Belviq has been tied to an increased risk of cancer in users and has been removed from the market in the United States due to the elevated cancer risk. Former Belviq and Belviq XR users began filing legal claims against the manufacturer of Belviq shortly after the U.S. Food and Drug Administration (FDA) requested that the company remove Belviq and Belviq XR from the market in February 2020. If you or someone you love took Belviq to lose weight and ended up being diagnosed with lung cancer, pancreatic cancer or colorectal cancer, know that you may have grounds to file a Belviq cancer lawsuit against the drug manufacturer. Contact our consumer advocates at Consumer Justice Foundation today to find out how we can help put you in touch with a knowledgeable Belviq cancer lawyer.
Individuals who are considered “obese” have a body mass index (BMI) of 30 or higher and are at risk for a number of other serious medical conditions, specifically type 2 diabetes, heart disease, stroke and premature death. Obese or severely overweight individuals struggling to lose weight with diet and exercise alone often turn to diet supplements or weight loss medications like Belviq that promise to help with chronic weight management. Unfortunately, many of these medications, Belviq included, come with a potential risk of major complications. For overweight or obese individuals hoping to avoid putting themselves at risk for serious side effects by taking a dangerous or defective medication, the following are some natural, fat-burning alternatives to taking Belviq to boost your weight-loss efforts:
January 2020 – The FDA warns in a drug safety communication that there is a possible increased risk of cancer associated with the weight loss drug Belviq and Belviq XR.
February 2020 – The FDA calls for Belviq and Belviq XR to be withdrawn from the market based on clinical trial data showing an increased occurrence of cancer among Belviq users. The agency encourages patients to stop using Belviq and talk to their healthcare providers about alternative weight loss options.
Drug manufacturing companies are responsible for the safety of their medications and should be held accountable for any harm users suffer as a result of the medications they develop and make available to consumers. If the makers of Belviq and Belviq XR were aware of serious, potentially life-threatening side effects linked to Belviq, like cancer, and failed to provide users and the medical community with adequate warnings, they may be liable for damages. Future lawsuits filed against Eisai Inc. over Belviq-related injuries are expected to raise the following allegations:
Obesity remains a serious public health problem in the United States and other countries. More than 40% of American adults are obese and the obesity epidemic has only gotten worse over the past 20 years. Unfortunately, there are limited treatment options for obesity beyond diet and exercise and many overweight individuals end up taking diet drugs like Belviq to manage their weight. Because Belviq users were not adequately informed about the link between the weight loss drug and cancer, they were not able to make an informed decision about whether the potential risk of cancer outweighed the weight loss benefits of the medication. If you have been diagnosed with lung cancer, colorectal cancer, pancreatic cancer or another type of cancer you believe to be related to the popular weight loss drug Belviq, do not hesitate to seek legal representation. Our consumer advocates at the Consumer Justice Foundation are committed to protecting the rights of consumers harmed by dangerous and defective medications and we can help put you in touch with an attorney who specializes in drug injury claims.